
This CRC project enabled the development of an efficient AAV-based method for CRISPRi-mediated epigenetic silencing of regulatory elements in cardiac myocytes in vivo and in vitro. This functional epigenetic approach offers a novel and efficient method for modulating gene expression in the heart and could become a standard approach for modeling cardiovascular disease and translational research.
This project enabled us to functionally test and resolve the spatial genome organization of cis-regulatory elements and genetic variants in atrial, ventricular, and failing human cardiomyocytes and linked them to heart disease traits, including heart failure and QT syndrome.